Updated Aug 17, 2026
/Rob Schneider says door remains open for Elle King amid estrangement/MLB, union at odds over Olympic participation rules as mandatory-play proposal draws resistance/Ian Poulter puts a number on LIV Golf's survival: $300 million, four weeks/Prince Harry longing for UK life as Sussex media revenue falls short of headline deals, sources say/Thirteen back-to-school buys worth the premium price, from backpacks to graphing calculators/Shannon Elizabeth's OnlyFans launch topped $1.2 million in first-week earnings, Variety reported, as she rules out dating after her divorce from Simon Borchert/Rob Schneider says door remains open for Elle King amid estrangement/MLB, union at odds over Olympic participation rules as mandatory-play proposal draws resistance/Ian Poulter puts a number on LIV Golf's survival: $300 million, four weeks/Prince Harry longing for UK life as Sussex media revenue falls short of headline deals, sources say/Thirteen back-to-school buys worth the premium price, from backpacks to graphing calculators/Shannon Elizabeth's OnlyFans launch topped $1.2 million in first-week earnings, Variety reported, as she rules out dating after her divorce from Simon Borchert

Investors Eye Biotech Stocks as FDA Pipeline Dynamics Shape Sector Returns

Biotech stocks — a healthcare subsector focused on developing drugs, treatments, and therapies for medical conditions, diseases, and viruses — carry outsized return potential tied directly to FDA approval decisions, according to a sector…

By Mara Whitfield2 min readHOOD
Share